The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Our very own Prof warning about potential triple whammy this winter
https://www.theguardian.com/world/2021/jul/15/act-now-or-nhs-could-be-overwhelmed-this-winter-report-says-covid-flu-rsv
One 90 year old died after being infected with 2 variants; one Portuguese 17 year old caught a second variant whilst recovering from a first infection, two Brazilians with simultaneous infection of gamma and another variant.
https://www.bbc.co.uk/news/health-57761343
I know these numbers are small, but these are the known ones. Crikey. SNG can't come online fast enough.
Hold fire.
Refers back to the source: https://clinicaltrials.gov/ct2/show/NCT04732949
Look at the start date. Jan 2021
Big Johnny,
Chart wise, novacyt will likely see further drops (not to say there won't be some short-term reprieve) but the SP has not reached the bottom. 280 is the first touch bottom, but may go to 250 or lower
Google translation for tweet posted by gggg21
Covid-19: a "mobile" trial to treat patients at home and avoid hospitalization
The Coverage clinical trial is evaluating two treatments, including inhaled interferon, in at-risk patients with severe, early-stage disease, with a visiting medical team. Meeting with the @CNGE_France teams
study partners.
Well put, WelshFalcon.
I only briefly watched the video and like anything else on the internet, it is worth checking the background of the interviewee or informer. I try not to take what is said online at face value. My first query was - who is he, what is his background. Is any of what he says true or a liberal use of facts? Haven't had a chance to check though not even sure I am bothered too. It IS fox news!
List of the 8 articles used in this study includes Synairgen's phase 2 results (obviously!)
https://www.icjournal.org/ViewImage.php?Type=T&aid=710266&id=T2&afn=86_IC_53_2_247&fn=ic-53-247-i002_0086IC
https://www.theguardian.com/world/2021/jul/03/fauci-delta-variant-cases-vaccines
...a Washington Post-ABC News poll released on Sunday found that 86% of Democrats but only 45% of Republicans have received at least one shot...
Fauci told NBC that of nearly 10,000 US deaths in June, “about 99.2% are unvaccinated. About 0.8% are vaccinated. No vaccine is perfect. But when you talk about the avoidability of hospitalisation and death, it’s really sad and tragic that most of these are avoidable and preventable.
No surprise that the black fungal problem is now a concern worldwide. Imagine if we have an agnostic antiviral that stops the lung getting badly infected in the first place.
“ But the combination of lungs battered by Covid, impaired immune systems, and both good and bad bacteria wiped out by antibiotics left critically ill patients exposed to moulds and spores.
“It’s an unfortunate perfect storm for these organisms, and we’re seeing it,” said Dr Tom Chiller, chief of the Mycotic Diseases Branch at the US-based Centers for Disease Control and Prevention (CDC).”
Source: https://www.theguardian.com/science/2021/jul/01/covid-perfect-storm-as-more-patients-hit-by-fungal-infections
Doc, when RM first said that I did also wonder why he would not just ‘get on with it’ and conduct an in-vitro study against the Delta variant. Initially I thought it was to save time and money, plus they don’t believe it to be necessary.
I’ve just realised that while this may be the case, I wonder if RM’s main reason is to encourage government agencies to initiate or to further dialogue.
Titania, I am more interested in this little titbit:
(full disclosure, I have an investment in some treatment innovators).
Very curious to know which treatment innovators he is invested in.
Thank you Misdosh
I am liking the clearer and positive message coming from RM.
“ Combined data from hospital and home cohorts totaling 221 patients in the Phase II SG016 trial (NCT04385095) showed 33 markedly or severely breathless patients treated with SNG001 were 3.41 times likelier to recover than placebo patients. Synairgen said the results reinforced confidence in its ongoing Phase III SG018 trial (NCT04732949) in hospitalized patients. The trial is expected to release data in the second half of 2021.
“Most people are going for early or very late treatment,” noted Richard Marsden, Synairgen’s CEO. “We’re kind of in the middle—with very strong effect sizes. We’re not interested in treating everybody in the home environment. What we want to do is find the breathless people at home, which is probably only about 10% of the non-hospitalized population.”
pmjh
I would agree with you except I found, when googling SNG001, a Yahoo business link was quoting the MF article! This gives MF a somewhat authoritative platform that it doesn't deserve. However, it does mean that the MF article could have some undue influence over SP to the uninformed.
Well I didn’t expect that victory!
Wouldn’t it be funny if my tongue-in-cheek prediction comes true (and yes, for the sensitive souls out there, my timeline ‘prediction’ was just a bit of fun)